Brussels, 01/07/2010 (Agence Europe) - On Friday 2 July in Turin, Italian scientist Milo Malanga will present details of new research into the development of an anti-cancer drug based on cyclodextrins, a type of sugar found in potatoes, wheat, corn or rice, at the Marie Curie conference in Turin (part of the 2010 EuroScience Open Forum). Malanga is working with a team of scientists and researchers at Budapest-based Cyclolab, the largest research and development laboratory of its type in the world. Results of the research into the anti-cancer treatment, known as Project Cyclon, are expected by 2013.
Malanga is one of the 396 research fellows who will be attending the Marie Curie conference, in the margins of the 2010 EuroScience Open Forum in Turin. The aim of the Marie Curie conference is for EU-backed researchers to broaden their knowledge and career perspectives. The EU's Marie Curie Actions provide grants at postgraduate and post-doctoral level to encourage mobility among Europe's best researchers. The EU will allocate more than €4.5 billion through the scheme in 2007-2013. Since 1996, Marie Curie Actions have played a central role in the “European Research Area”. They are managed by the Research Executive Agency (REA), a funding body created by the EU to manage parts of the European Seventh Framework Programme for Research.
Research, Innovation and Science Commissioner Máire Geoghegan-Quinn will address the 2010 EuroScience Open Forum in Turin on 3 July on how the Commission's forthcoming Innovation Union strategy will boost scientific progress and sustainable prosperity and how the Joint Research Centre's new strategy will contribute to those goals. (O.L./transl.fl)